Comend builds collaborative tools for the rare disease community and researchers to bring new treatments to market.
Comend has raised $765K in total funding. The most recent round was Pre-Seed. The last funding was announced in April 2023.
Comend's investors include Drive Capital, Character, PharmStars.
Comend is headquartered in Toronto, Canada.
Comend builds collaborative tools for the rare disease community and researchers to bring new treatments to market.
Comend is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Comend — Funding & Investors." VCBacked, April 2, 2023, https://www.vcbacked.co/company/comend. Accessed August 14, 2026.
VCBacked. (2023). Comend — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/comend
{{cite web |title=Comend — Funding & Investors |url=https://www.vcbacked.co/company/comend |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated